| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 5 |
| 1 | ETONOGESTREL AND ETHINYL ESTRADIOL | 5 |
| 2 | FINASTERIDE | 5 |
| 3 | NIVOLUMAB | 4 |
| 4 | OMEPRAZOLE MAGNESIUM | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | CLOPIDOGREL BISULFATE | 3 |
| 7 | ERGOCALCIFEROL | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | CLOPIDOGREL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRASTUZUMAB AND HYALURONIDASE-OYSK | 1 | 0.0093 |
| 1 | CANTHARIDIN | 1 | 0.0055 |
| 2 | TRASTUZUMAB-QYYP | 1 | 0.0026 |
| 3 | MEBENDAZOLE | 1 | 0.0013 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 5 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0011 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| 7 | BROMFENAC SODIUM | 1 | 0.0007 |
| 8 | POTASSIUM ACETATE | 1 | 0.0007 |
| 9 | MINERAL OIL | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 7 |
| 1 | Progestin [EPC] | 7 |
| 2 | Factor Xa Inhibitor [EPC] | 6 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 5 |
| 4 | Corticosteroid [EPC] | 5 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 |
| 7 | Kinase Inhibitor [EPC] | 3 |
| 8 | Aromatase Inhibitor [EPC] | 2 |
| 9 | Benzodiazepine [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | Progesterone [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 6 | Estrogen [EPC] | 7 | 0.0000 |
| 7 | Androgen [EPC] | 1 | 0.0000 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |